Shoncef T 1000mg/125mg Injection
Marketer
Schon Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Shoncef T 1000mg/125mg Injection
Cefixime and Sulbactam injection (1000mg/125mg) is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection progression. This injection must be administered only by a healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation can compromise effectiveness. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects require immediate medical attention. Allergic reactions (skin rash, itching, swelling, respiratory distress) necessitate prompt medical assistance. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration contribute to faster recovery. Your physician may request blood tests and other diagnostic procedures to monitor treatment efficacy.
Uses of Shoncef T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Shoncef T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shoncef T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Shoncef T 1000mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Shoncef T 1000mg/125mg Injection works:
Ceftriaxone and Tazobactum, combined as Shoncef T 1000mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. The addition of Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Shoncef T 1000mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Shoncef T (1000mg/125mg) is typically regarded as safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are currently insufficient.
Breast feedingCAUTION
The administration of Shoncef T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Shoncef T 1000mg/125mg Injection may induce drowsiness, visual disturbances, or dizziness. Operation of machinery, including driving, should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Shoncef T 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Shoncef T 1000mg/125mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Shoncef T 1000mg/125mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Shoncef T 1000mg/125mg Injection :
Should you forget a scheduled Shoncef T 1000mg/125mg Injection, seek advice from your physician.
Facts to Know About Shoncef T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently